dactinomycin has been researched along with Liver Cirrhosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandes, RP; Chen, X; Devaraj, S; Jiang, JX; Page, P; Schröder, K; Serizawa, N; Szyndralewiez, C; Török, NJ | 1 |
BRITTAIN, RS; HERMANN, G; MARCHIORO, TL; STARZL, TE; VONKAULLA, KN; WADDELL, WR | 1 |
Brigham, MP; Reichle, FA; Reichle, RM; Reilly, M; Rosemond, GP; Tyson, RR | 1 |
MacDonald, RA; MacSween, RN; Pechet, GS | 1 |
Kagan, AR | 1 |
5 other study(ies) available for dactinomycin and Liver Cirrhosis
Article | Year |
---|---|
Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Topics: Animals; Apoptosis; Bile Ducts; Dactinomycin; Fas Ligand Protein; Gene Deletion; Hepatic Stellate Cells; Hepatitis, Autoimmune; Hepatocytes; Humans; Ligation; Liver; Liver Cirrhosis; Mice; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Pyrazoles; Pyrazolones; Pyridines; Pyridones; Rats; Reactive Oxygen Species; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta | 2012 |
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS.
Topics: Autopsy; Carcinoma, Hepatocellular; Child; Dactinomycin; Geriatrics; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Perfusion; Postoperative Complications; Prednisone; Pulmonary Embolism; Transplantation; Transplantation, Homologous | 1963 |
Effect of portacaval shunt on tyrosine metabolism.
Topics: Amino Acids; Animals; Body Weight; Dactinomycin; Glucose; Humans; Liver; Liver Cirrhosis; Organ Size; Phenylpyruvic Acids; Portacaval Shunt, Surgical; Rats; Tyrosine; Tyrosine Transaminase | 1972 |
Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation.
Topics: Animals; Ascorbic Acid; Cobalt; Copper; Cysteine; Dactinomycin; Deferoxamine; Dinitrophenols; Edetic Acid; Fatty Liver; Fluorides; Fructose; Glucose; Glutathione; Hemochromatosis; Inflammation; Iodoacetates; Iron; Lipotropic Agents; Liver Cirrhosis; Lung; Macrophages; Microscopy, Electron; Potassium Permanganate; Protein Biosynthesis; Puromycin; Rabbits; RNA; Saponins; Sucrose; Surface-Active Agents; Transferrin; Trypsin | 1969 |
Comments on morbidity in present-day radiotherapy.
Topics: Breast Neoplasms; Buttocks; Carcinoma, Squamous Cell; Dactinomycin; Erythema; Female; Fluorouracil; Hodgkin Disease; Humans; Laryngeal Neoplasms; Liver Cirrhosis; Methotrexate; Morbidity; Myelitis; Pharyngeal Neoplasms; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Uterine Cervical Neoplasms; Xerostomia | 1971 |